Chart calendar Pharvaris N.V.

f1ec78f26a76.ywoLtY6p6tvZM8RY5rUVZsVgb6IeLW5TCFdqQ0MlTfM.nF5igMb-0qm7drRtvs95FPQ5PuxKQxthfTowIXtyB5yqeFvmvM28npRXqw~31d13a4a186fac36aa31e70fa0acd216

Upcoming events on Pharvaris N.V.

2025-06-27 10:00 Annual General Meeting
2025-07-24 Q2 2025 Earnings Release (Projected)
2025-11-04 Q3 2025 Earnings Release (Projected)
2026-04-13 Q4 2025 Earnings Release (Projected)
2026-05-12 Q1 2026 Earnings Release (Projected)

Past events on Pharvaris N.V.

Today 10:45 European Academy of Allergy and Clinical Immunology Congress - Abstract No:000044, OAS18
Today 09:00 European Academy of Allergy and Clinical Immunology Congress - Abstract No:000076, FT16
Today 09:00 European Academy of Allergy and Clinical Immunology Congress - Abstract No:000075, FT16
Today 09:00 European Academy of Allergy and Clinical Immunology Congress - Abstract No:000068, FT16
Today 07:45 European Academy of Allergy and Clinical Immunology Congress - Abstract No:000331
2025-06-14 07:00 European Academy of Allergy and Clinical Immunology Congress - Abstract No:000070
2025-06-14 07:00 European Academy of Allergy and Clinical Immunology Congress - Abstract No:000069
2025-06-11 16:00 Goldman Sachs Global Healthcare Conference - Fireside Chat
2025-06-04 08:00 R&D Day
2025-05-31 10:45 C1-Inhibitor Deficiency and Angioedema Conference - Poster No:P-55
2025-05-31 10:45 C1-Inhibitor Deficiency and Angioedema Conference - Poster No: P-56
2025-05-31 10:15 C1-Inhibitor Deficiency and Angioedema Conference - Poster No: P-30
2025-05-31 09:45 C1-Inhibitor Deficiency and Angioedema Conference - Marc A. Riedl, M.D., M.S
2025-05-31 09:30 C1-Inhibitor Deficiency and Angioedema Conference - Emel Aygören-Pürsün, M.D
2025-05-30 09:45 C1-Inhibitor Deficiency and Angioedema Conference - Poster No: P-17
2025-05-30 09:45 C1-Inhibitor Deficiency and Angioedema Conference - Poster No:P-20
2025-05-30 09:45 C1-Inhibitor Deficiency and Angioedema Conference - Poster No: P-19
2025-05-30 09:45 Eastern Allergy Conference - John Anderson, M.D
2025-05-30 02:45 C1-Inhibitor Deficiency and Angioedema Conference - Evangelia Pardali, Ph.D
2025-05-29 10:00 Bradykinin Mediated Angioedema Symposium

Annual results

Fiscal PeriodDecember 2022 2023 2024 2025 2026 2027
Net sales
Million EUR
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


1,51


50,9

EBITDA
Million EUR
Released
Forecast
Spread
-75,2
-83,1
9.45%
-86,0
-90,3
4.76%
-129
-133
2.99%

-172


-192


-158

EBIT
Million EUR
Released
Forecast
Spread
-86,7
-84,2
-2.96%
-96,9
-92,8
-4.42%
-146
-137
-6.2%

-176


-202


-165

Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
-75,7
-60,6
-24.82%
-99,8
-93,4
-6.84%
-132
-136
2.85%

-171


-200


-165

Net income
Million EUR
Released
Forecast
Spread
-76,3
-61,9
-23.37%
-101
-91,9
-9.78%
-134
-138
2.92%

-171


-194


-165

EPS
EUR
Released
Forecast
Spread
-2,27
-1,83
-24.16%
-2,63
-2,30
-14.49%
-2,48
-2,65
6.42%

-3,05


-3,12


-2,50

Announcement Date05/04/2310/04/2407/04/25-

Quarterly results

Fiscal PeriodMarch 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4 2026 Q1 2026 Q2 2026 Q3 2026 Q4
Net sales
Million EUR
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00


0,00


0,00


0,00

EBITDA
Million EUR
Released
Forecast
Spread



-24,6
-27,7
11.2%









-40,2
-40,6
1.04%
























EBIT
Million EUR
Released
Forecast
Spread
-26,2
-23,2
-12.91%
-27,2
-26,2
-3.6%
-28,3
-28,7
1.31%
-34,4
-30,1
-14.04%
-37,9
-34,7
-9.11%
-45,1
-39,4
-14.31%
-42,2
-46,5
9.33%

-44,5


-45,7


-47,1


-48,6


-49,9


-51,5


-53,8

Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
-23,5
-22,1
-6.32%
-32,0
-25,6
-24.96%
-27,7
-27,5
-0.9%
-29,7
-30,4
2.48%
-41,5
-32,6
-27.21%
-33,5
-37,4
10.37%
-46,0
-45,6
-1.04%

-44,2


-45,6


-46,7


-48,3


-49,7


-51,4


-53,4

Net income
Million EUR
Released
Forecast
Spread
-23,6
-22,0
-7.21%
-32,7
-25,6
-27.88%
-28,0
-27,4
-2.41%
-29,7
-29,9
0.5%
-41,7
-33,5
-24.54%
-34,8
-38,3
9.22%
-46,3
-44,7
-3.59%

-43,0


-44,5


-45,7


-48,3


-49,7


-51,4


-53,4

EPS
EUR
Released
Forecast
Spread
-0,58
-0,61
5.29%
-0,76
-0,57
-34.32%
-0,52
-0,55
5.45%
-0,55
-0,56
1.39%
-0,77
-0,62
-24.66%
-0,64
-0,71
10.05%
-0,85
-0,83
-2.72%

-0,78


-0,80


-0,83


-0,80


-0,82


-0,84


-0,87

Announcement Date02/11/2310/04/2408/05/2414/08/2413/11/2407/04/2513/05/25-------

Quarterly revenue - Rate of surprise

Net sales - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. PHVS Stock
  4. Calendar Pharvaris N.V.